higenamine has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, T; Deng, X; Fu, Q; Gael, A; Hang, L; Lai, J; Li, Z; Liu, Y; Wei, Z; Yan, Q | 1 |
| Ling, W; Wu, MP; Xue, C; Yan, C; Zhang, YS; Zhou, Z; Zhu, JX | 1 |
2 other study(ies) available for higenamine and Cirrhosis
| Article | Year |
|---|---|
Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway.
Topics: Alkaloids; Animals; Cardio-Renal Syndrome; Cells, Cultured; Collagen; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Kidney; Male; MAP Kinase Kinase Kinase 5; Myocytes, Cardiac; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction; Tetrahydroisoquinolines | 2020 |
Higenamine attenuates cardiac fibroblast abstract and fibrosis via inhibition of TGF-β1/Smad signaling.
Topics: Actins; Adrenergic beta-Agonists; Alkaloids; Animals; Aorta; Apoptosis; Cardiomegaly; Fibrinolytic Agents; Fibroblasts; Fibrosis; Heart Diseases; Hypertension; Isoproterenol; Mice; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Tetrahydroisoquinolines; Transforming Growth Factor beta1 | 2021 |